Kalaitzakis Evangelos, Panos Marios, Sadik Riadh, Aabakken Lars, Koumi Andriani, Meenan John
Department of Gastroenterology, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Scand J Gastroenterol. 2009;44(1):100-7. doi: 10.1080/00365520802495545.
Despite the documented effectiveness of endoscopic ultrasound (EUS) in research studies, data on the utilization of this technology in clinical practice are scarce. The aim of this study was to assess EUS availability and accessibility as well as EUS utilization among clinicians from different European countries.
A direct mail survey was sent to members of the national gastroenterological associations in Sweden, Norway, Greece, and the United Kingdom.
Out of 2361 clinicians with valid addresses, 593 (25.1%) responded. Overall, EUS was available to 43% of clinicians within their practice but availability varied from 23% in Greece to 56% in the United Kingdom. More than 50% of respondents evaluating patients with esophageal cancer, rectal cancer, or pancreaticobiliary disorders had utilized EUS during the previous year, but utilization varied considerably among different countries, being more frequent in the United Kingdom. In logistic regression analyses, factors independently related to EUS utilization were mainly EUS availability and accessibility as well as perceived utility of EUS (p <0.05 for all). Respondents considered the lack of trained endosonographers (79%) and high cost (52%) as the main barriers to wider EUS use.
The majority of responding clinicians use EUS but overall utilization varies considerably among different countries. There is considerable variation in EUS service availability and accessibility among countries which, together with perceived usefulness of EUS, is a major determinant of EUS utilization. A shortage of trained endosonographers and the high cost are major barriers to wider EUS use. The findings of this study might help to define policies aimed at development of EUS services.
尽管内镜超声(EUS)在研究中的有效性已有文献记载,但关于该技术在临床实践中的应用数据却很匮乏。本研究的目的是评估不同欧洲国家临床医生对EUS的可获得性、可及性以及EUS的使用情况。
向瑞典、挪威、希腊和英国的国家胃肠病学协会成员发送了直接邮件调查问卷。
在2361名有有效地址的临床医生中,593名(25.1%)回复了问卷。总体而言,43%的临床医生在其执业机构中可以使用EUS,但可获得性在希腊为23%,在英国为56%。在去年,超过50%评估食管癌、直肠癌或胰胆疾病患者的受访者使用过EUS,但不同国家之间的使用情况差异很大,在英国更为频繁。在逻辑回归分析中,与EUS使用独立相关的因素主要是EUS的可获得性、可及性以及对EUS的感知效用(所有p<0.05)。受访者认为缺乏经过培训的内镜超声检查人员(79%)和成本高昂(52%)是更广泛使用EUS的主要障碍。
大多数回复的临床医生使用EUS,但不同国家之间的总体使用情况差异很大。各国在EUS服务的可获得性和可及性方面存在很大差异,这与对EUS的感知有用性一起,是EUS使用的主要决定因素。缺乏经过培训的内镜超声检查人员和成本高昂是更广泛使用EUS的主要障碍。本研究的结果可能有助于制定旨在发展EUS服务的政策。